SHOP APOTHEKE EUROPE : N.V. strengthens management team with Stefan Feltens, former CFO of Teva Global Operations, and confirms mid-term annual revenue target of 1 bn EUR.

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Change of Personnel SHOP APOTHEKE EUROPE N.V. strengthens management team with Stefan Feltens, former CFO of Teva Global Operations, and confirms mid-term annual revenue target of 1 bn EUR. 17.09.2018 / 21:05 The issuer is solely responsible for the content of this announcement. SHOP APOTHEKE EUROPE N.V. strengthens management team with Stefan Feltens, former CFO of Teva Global Operations, and confirms mid-term annual revenue target of 1 bn EUR. Venlo, the Netherlands, 17 September 2018. The leading online pharmacy in continental Europe, SHOP APOTHEKE EUROPE N.V., is in the process of strengthening its management in order to support its further European expansion. The supervisory board has affirmed the resolution of the managing board to appoint Stefan Feltens (54) as Manager of Purchasing and Human Resources with immediate effect und as CEO as of 1 January 2019. In this position, he will succeed Michael Köhler (55), who after 17 years with the company will resign as CEO effective 31 December 2018. Michael will continue to actively support SHOP APOTHEKE EUROPE N.V. as a consultant for its international expansion and M&A. "I am glad that Stefan Feltens will strengthen our entrepreneurial management team with his extensive international experience. He brings to the table the required management and industry knowledge needed to achieve our next revenue milestone of 1 billion EUR per year. I will continue to be personally involved on a consultant basis and as the company's largest shareholder", comments Michael Köhler, CEO. The designated CEO Stefan Feltens adds: "I am excited to work closely with the managing board to take the growth story of SHOP APOTHEKE EUROPE to the next level." Stefan Feltens has many years of international experience in the pharmaceutical industry and until recently worked as Chief Financial Officer for Teva Global Operations, a division of the world's leading generics company Teva Pharmaceuticals Industries Ltd. with annual sales of USD 20 billion. As a long-term shareholder of Europa Apotheek and current shareholder of SHOP APOTHEKE EUROPE N.V., he is familiar with SHOP APOTHEKE's online pharmacy business. In accordance with Dutch law, Stefan Feltens will be proposed to be appointed as a member of the managing board by the next general shareholders' meeting of SHOP APOTHEKE EUROPE N.V. ABOUT SHOP APOTHEKE EUROPE. SHOP APOTHEKE EUROPE is the leading and fastest growing online pharmacy in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership with an expanded product range for the whole family in the areas of OTC, beauty and personal care products as well as prescription drugs. SHOP APOTHEKE EUROPE already operates online pharmacies in Germany, Austria, France, Belgium, Italy, Spain and the Netherlands. In Germany, the TÜV-certified shop-apotheke.com is the clear market leader. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 3 million active customers fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services. SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and will form part of the SDAX on 24 September 2018.   MEDIA CONTACTS. Trade and popular media: Sven Schirmer Mobile: [phone] Email: [e-mail] Financial media: Thomas Schnorrenberg Mobile [phone] Email: [e-mail] Investor relations: Dr. Ulrich Wandel Phone: [phone] Email: [e-mail] DISCLAIMER. This release contains statements that relate to future business performance and future financial performance, as well as to events or developments pertaining to SHOP APOTHEKE EUROPE, and that may constitute forward-looking statements. These statements are based on current expectations and assumptions by SHOP APOTHEKE EUROPE's management, a large number of which are beyond the control of SHOP APOTHEKE EUROPE. They are therefore subject to a variety of risks and uncertainties. If these risks and uncertainties materialize, or the underlying expectations do not materialize or the assumptions made prove incorrect, actual events, both in a positive and negative sense, may differ materially from those described or implied in the forward-looking statements. SHOP APOTHEKE EUROPE undertakes no obligation to update these forward-looking statements or to correct them in any other than anticipated development. SHOP APOTHEKE EUROPE also does not intend to do so. 17.09.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	SHOP APOTHEKE EUROPE N.V.
	Dirk Hartogweg 14
	5928 LV Venlo
	Netherlands
Phone:	0800 - 200 800 300
Fax:	0800 - 90 70 90 20
E-mail:	[e-mail]
Internet:	www.shop-apotheke-europe.com
ISIN:	NL0012044747, DE000A19Y072
WKN:	A2AR94, A19Y07
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

End of News	DGAP News Service

724483  17.09.2018